PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
PROCEPT BioRobotics reported a 19% revenue increase to $94.5 million in Q2 2026 driven by growth in U.S. system and consumable sales, with 21% more procedures completed and 65 new HYDROS system placements. The company achieved strategic milestones including completing enrollment in a prostate cancer study and reinforcing Aquablation therapy's recom…